Can SynaQuell+™ Help Clear Brain Fog in Long COVID and ME/CFS?

SynaQuell+™ is an advanced, multi-ingredient dietary supplement meticulously formulated by Thorne Research to provide comprehensive support for brain health and cognitive function. Unlike standard daily multivitamins, this formulation was specifically designed to address acute neurological stress, enhance cellular energy production, and promote a healthy balance of inflammatory cytokines within the central nervous system. Its development was heavily influenced by clinical neurologists, including experts from the Mayo Clinic, who sought to create a nutritional intervention capable of supporting the brain's healing processes following sub-concussive impacts and traumatic brain injuries.

However, the underlying pathophysiology of a traumatic brain injury shares remarkable similarities with the neurological damage seen in post-viral syndromes. Both conditions are characterized by a sudden and severe disruption in how the brain utilizes energy, accompanied by a cascade of neuroinflammation and oxidative stress. Because SynaQuell+ was engineered to rescue the brain from these exact mechanisms, it has emerged as a highly relevant and biologically plausible intervention for individuals suffering from the profound cognitive dysfunction associated with Long COVID and ME/CFS. By delivering clinical doses of targeted nutrients, it aims to restore the brain's fundamental operational capacity.

The complexity of brain fog in chronic illness requires a multi-targeted approach, as no single pathway is responsible for the symptom. SynaQuell+ provides a robust blend of nutrients designed to address energy deficits, inflammation, and oxidative stress simultaneously. By combining exogenous ketones, essential amino acids, and advanced botanical extracts, this formula offers a comprehensive strategy for those struggling with the cognitive sequelae of complex chronic conditions, providing the raw materials the brain desperately needs to rebuild and repair its intricate neural networks.

At the heart of the SynaQuell+ formula is a powerful dose of Beta-hydroxybutyrate (BHB), delivered as magnesium beta-hydroxybutyrate. BHB is a ketone body, a highly efficient alternative fuel source that the body naturally produces during states of fasting or carbohydrate restriction. The brain is a massive consumer of energy, typically relying almost exclusively on glucose. However, when glucose metabolism fails—a common occurrence in neuro-inflammatory states—BHB can cross the blood-brain barrier and supply up to 70 percent of the brain's energy needs, bypassing the broken metabolic pathways to feed starving neurons directly.

Complementing this alternative fuel is Nicotinamide Riboside (NR), a highly efficient precursor to NAD+ (Nicotinamide Adenine Dinucleotide). NAD+ is the absolute linchpin of cellular respiration; it is the critical coenzyme required by the mitochondria to convert food into ATP, the energetic currency of the cell. By delivering 415 mg of NR, SynaQuell+ actively works to replenish the cellular NAD+ pool, which is frequently drained by the hyperactive immune responses seen in persistent viral infections. This replenishment is essential for rescuing the mitochondria from a state of energetic failure.

The synergy between BHB and NR creates a powerful two-pronged approach to restoring the brain's energy infrastructure. While BHB provides the clean-burning, alternative fuel required to bypass immediate metabolic blockades, NR ensures that the mitochondrial machinery has the necessary coenzymes to process that fuel into usable ATP. Together, they form the energetic foundation of the SynaQuell+ formula, directly addressing the profound cellular exhaustion that manifests clinically as debilitating brain fog and cognitive fatigue.

Beyond energy production, the brain requires a delicate balance of chemical messengers to maintain focus, mood, and cognitive clarity. SynaQuell+ includes a substantial 2.5-gram dose of Branched-Chain Amino Acids (BCAAs)—specifically L-Leucine, L-Isoleucine, and L-Valine. These essential amino acids readily cross the blood-brain barrier, where they serve as vital precursors for the synthesis of key neurotransmitters, including dopamine, serotonin, and norepinephrine. During periods of chronic physiological stress, the body's amino acid pools can become severely depleted, leading to neurotransmitter imbalances that exacerbate apathy, depression, and mental fatigue.

To combat the destructive forces of oxidative stress, the formula incorporates a robust antioxidant defense system featuring Coenzyme Q10 (CoQ10) phytosome, Glutathione, and Riboflavin. When the brain is inflamed, malfunctioning mitochondria leak massive amounts of reactive oxygen species (ROS), which damage delicate nerve tissues and cellular membranes. Glutathione, often referred to as the body's master antioxidant, works in tandem with the highly bioavailable CoQ10 phytosome to neutralize these free radicals directly at the source, protecting the structural integrity of the neurons and halting the cycle of oxidative damage.

Finally, SynaQuell+ targets neuroinflammation through the inclusion of potent botanical extracts and essential fatty acids, namely Curcumin Phytosome, Trans-Resveratrol, and DHA (from algal oil). DHA is a critical structural component of brain cell membranes and plays a vital role in resolving inflammatory responses. Meanwhile, curcumin and resveratrol act at the genetic level to downregulate the pathways responsible for cytokine storms. Together, these ingredients work to calm the hyperactive immune cells within the brain, creating a physiological environment conducive to healing and optimal cognitive function.

To understand why a supplement like SynaQuell+ is necessary, we must first examine how complex chronic illnesses like Long COVID and ME/CFS fundamentally alter the brain's operational capacity. Current functional neuroimaging and metabolic studies have revealed that these post-viral syndromes trigger a state of profound cerebral glucose hypometabolism. In a healthy state, the brain relies almost entirely on glucose, utilizing complex glycolytic pathways to generate the massive amounts of ATP required for continuous neural firing. However, viral trauma and cellular damage severely interfere with the brain's ability to transport and utilize this primary fuel source.

When glucose metabolism is broken, the brain essentially begins to starve, even if blood sugar levels are perfectly normal. The mitochondria—the energy powerhouses of the neurons—become fragmented and dysfunctional, resulting in a severe drop in ATP production. This metabolic failure means that the neural networks responsible for memory retrieval, executive function, and sustained attention simply lack the energetic currency required to operate. This is the physiological reality behind the symptom we call brain fog; it is not a psychological lack of effort, but a literal energy crisis within the central nervous system.

This energy deficit is further compounded by the systemic nature of these illnesses. When the brain cannot generate enough ATP through efficient oxidative phosphorylation, it is forced to rely on emergency, anaerobic pathways. This inefficient process produces minimal energy while generating toxic byproducts like lactic acid, which further impairs cellular function. To explore the clinical manifestations of this metabolic failure in greater detail, you can read our comprehensive guide on What Is “Brain Fog” and Cognitive Dysfunction in Long COVID?.

Alongside the energy crisis, patients with Long COVID, ME/CFS, and mast cell activation syndrome (MCAS) suffer from chronic, smoldering neuroinflammation. Viral infections like SARS-CoV-2 can trigger a sustained, hyperactive immune response, leading to the systemic release of pro-inflammatory cytokines such as Interleukin-6 (IL-6) and Tumor Necrosis Factor-alpha (TNF-α). These inflammatory molecules can breach the blood-brain barrier or signal through the vagus nerve, directly communicating the body's inflammatory state to the central nervous system.

Once inside the brain, these cytokines activate microglia, the brain's resident immune cells. In a healthy brain, microglia act as gentle housekeepers, clearing away cellular debris. However, when activated by systemic inflammation, they shift into an aggressive, neurotoxic state, releasing their own localized inflammatory mediators. This microglial activation disrupts synaptic communication, damages surrounding neurons, and significantly impairs neuroplasticity—the brain's ability to adapt and form new connections.

This localized neuroinflammation creates a vicious, self-perpetuating cycle. The inflammation damages the mitochondria, which worsens the energy crisis. The failing mitochondria then leak reactive oxygen species, which causes further tissue damage and triggers even more microglial activation. Breaking this cycle requires targeted interventions that can simultaneously calm the immune response and rescue the failing mitochondria, a dual-action approach that forms the core rationale for multi-ingredient cognitive support formulas.

The intersection of mitochondrial dysfunction and neuroinflammation inevitably leads to massive oxidative stress. A recent landmark study from Stanford University highlighted that the immune cells of patients with ME/CFS and Long COVID produce dramatically higher levels of reactive oxygen species (ROS) compared to healthy controls. This severe redox imbalance causes lipid peroxidation—the literal degradation of the cellular membranes that protect the brain's neurons. As the membranes degrade, the cells lose their ability to communicate effectively, further deepening the cognitive fog.

To repair the extensive DNA and cellular damage caused by this oxidative stress, the body hyperactivates an enzyme known as PARP1. While PARP1 is essential for DNA repair, it consumes massive amounts of NAD+ in the process. During severe or lingering viral infections, this PARP1 hyperactivation completely drains the cell's NAD+ reserves. Because NAD+ is an absolute requirement for mitochondrial ATP production, this drain effectively paralyzes the cell's energy infrastructure, creating a biological bottleneck that prevents recovery.

Without adequate NAD+, the brain is trapped in a state of energetic starvation. This mechanism explains why patients experience profound post-exertional malaise (PEM)—even minimal cognitive or physical exertion demands ATP that the body simply cannot produce, leading to a debilitating "crash." Understanding this pathway is crucial, as it highlights why simply resting is often insufficient for recovery; the biochemical bottleneck must be actively bypassed or repaired through targeted nutritional interventions.

Finally, chronic illness fundamentally alters systemic amino acid profiles, leading to severe neurotransmitter imbalances. Recent metabolomic research by Fluge et al. has shown that patients with ME/CFS often have chronically depleted baseline levels of circulating branched-chain amino acids (BCAAs). This depletion has profound consequences at the blood-brain barrier, specifically at the Large Neutral Amino Acid Transporter (LAT1), the single gateway that BCAAs and aromatic amino acids (like tryptophan and tyrosine) must share to enter the brain.

When BCAA levels are abnormally low, the LAT1 transporter is left wide open for free tryptophan. Tryptophan floods into the brain unchecked, where it is rapidly converted into massive amounts of serotonin. While serotonin is often thought of as a "happy" chemical, unregulated spikes in brain serotonin cause a sensation of profound lethargy, loss of motivation, and central nervous system fatigue. This mechanism, known as the Central Fatigue Hypothesis, explains the crushing physical exhaustion that accompanies cognitive tasks in post-viral syndromes.

Conversely, if the brain is starved of tyrosine (the precursor to dopamine) due to this transporter imbalance, the patient will experience severe apathy, lack of focus, and an inability to sustain attention. The delicate tug-of-war at the blood-brain barrier dictates our cognitive clarity and drive. When chronic illness disrupts this balance, it requires precise, free-form amino acid therapy to restore the proper ratios and clear the chemically induced brain fog. You can learn more about this specific mechanism in our guide on Can Free-Form Amino Acids Support Energy and Brain Fog in Long COVID and ME/CFS?.

When the brain's primary glucose metabolism is compromised by post-viral dysfunction, SynaQuell+ steps in to provide a metabolic rescue via Beta-hydroxybutyrate (BHB). As an exogenous ketone, BHB offers a highly efficient, alternative "clean-burning" fuel that completely bypasses the impaired glycolytic steps that are failing in Long COVID and ME/CFS patients. BHB crosses the blood-brain barrier via monocarboxylate transporters and enters the brain cells independently of the insulin-dependent glucose pathways, ensuring rapid delivery of energy to starving neurons.

Once inside the mitochondria, BHB is oxidized to produce ATP. Remarkably, as an oxidative fuel, BHB produces over 20% more ATP per molecule than glucose, effectively restoring the brain's energy deficits. Furthermore, research indicates that the presence of BHB stimulates mitochondrial biogenesis—the creation of entirely new, healthy mitochondria. This not only provides immediate energy but actively rebuilds the cellular energy infrastructure that viral infections tend to damage, offering a sustainable pathway out of the cognitive fog.

Beyond its role as a fuel, BHB acts as a potent signaling metabolite that directly combats neuroinflammation. It has been shown to actively inhibit the NLRP3 inflammasome, a key immune complex responsible for the release of the pro-inflammatory cytokines that drive Long COVID symptoms. By activating the GPR109A receptor, BHB promotes neuroprotective pathways, effectively switching off the inflammatory cascades while simultaneously turning the lights back on in the brain's energy centers.

To address the severe NAD+ drain caused by PARP1 hyperactivation, SynaQuell+ utilizes Nicotinamide Riboside (NR). NR is a highly efficient, clinically proven precursor to NAD+ that utilizes the body's salvage pathways to bypass the metabolic bottlenecks created by viral infections. By providing a direct building block for NAD+, NR allows the cells to rapidly replenish their coenzyme reserves, which is an absolute prerequisite for restarting mitochondrial oxidative phosphorylation and generating ATP.

The restoration of NAD+ has profound downstream effects on cognitive function. When NAD+ levels are normalized, the mitochondria can shift away from inefficient, lactate-producing anaerobic glycolysis and return to healthy, high-yield energy production. This directly alleviates the cellular exhaustion that drives post-exertional malaise (PEM) and mental fatigue. Furthermore, adequate NAD+ is required for the activation of sirtuins, a family of proteins that regulate cellular health, DNA repair, and resistance to oxidative stress, providing long-term neuroprotection.

Recent clinical trials, including a 2025 randomized controlled trial published in eClinicalMedicine, have demonstrated that high-dose NR supplementation successfully resolves cellular NAD+ deficits in Long COVID patients, leading to self-reported improvements in fatigue, sleep quality, and executive function. By including a substantial 415 mg dose of NR, SynaQuell+ directly targets this critical biological vulnerability.

To break the vicious cycle of microglial activation and cytokine storms, SynaQuell+ deploys a synergistic blend of Curcumin Phytosome, Trans-Resveratrol, and DHA. Curcumin is a master regulator of inflammation, capable of crossing the blood-brain barrier to directly inhibit the NF-κB and TLR4 pathways. These are the primary genetic switches that command the immune system to release neurotoxic cytokines. By turning off these switches, curcumin effectively calms the hyperactive microglia that drive post-viral brain fog. You can read more about this specific botanical in our article, Can CurcumaSorb Mind Help Clear Brain Fog in Long COVID and ME/CFS?.

Working alongside curcumin is Trans-Resveratrol, a potent polyphenol that regulates mitochondrial health and promotes autophagy—the cellular process of clearing out damaged debris. Resveratrol is uniquely capable of acting on the gut-brain axis, helping to tighten the gut barrier and reduce the systemic inflammation that frequently accompanies Long COVID. Additionally, it exhibits anti-platelet activating factor (anti-PAF) activity, which helps prevent the micro-clotting that can deprive the brain of optimal oxygen and nutrient flow.

Finally, DHA (Docosahexaenoic Acid) provides the structural foundation for resolving neuroinflammation. As an essential omega-3 fatty acid, DHA is heavily concentrated in the membranes of brain cells. It serves as a direct precursor to specialized pro-resolving mediators (SPMs), such as resolvins and protectins. These molecules actively signal the immune system to "turn off" the inflammatory cascade, sealing the leaky blood-brain barrier and promoting a healthy balance of inflammatory cytokines, crucial for maintaining neuronal integrity and cognitive clarity.

To address the Central Fatigue Hypothesis and the imbalance at the LAT1 transporter, SynaQuell+ provides a precise 2.5-gram dose of Branched-Chain Amino Acids (BCAAs). By elevating circulating levels of leucine, isoleucine, and valine, the supplement effectively creates healthy competition at the blood-brain barrier. This prevents free tryptophan from flooding the central nervous system unchecked, thereby halting the unregulated spikes in serotonin that cause profound physical lethargy and post-exertional crashes.

Furthermore, once inside the brain, these BCAAs serve as vital precursors and metabolic regulators for the synthesis of excitatory neurotransmitters. By ensuring a steady supply of the necessary amino acid building blocks, SynaQuell+ supports the continuous production of dopamine and norepinephrine. These neurotransmitters are absolutely essential for executive function, motivation, sustained attention, and mood regulation, directly counteracting the apathy and cognitive slowing that characterize severe brain fog.

The final pillar of SynaQuell+'s mechanism is its aggressive neutralization of oxidative stress, utilizing Coenzyme Q10 (CoQ10) phytosome and Glutathione. CoQ10 is a fat-soluble antioxidant that is structurally essential for the electron transport chain within the mitochondria. By restoring depleted CoQ10 levels, the supplement allows the mitochondria to efficiently pass electrons and generate ATP without leaking destructive reactive oxygen species (ROS) into the cellular environment.

To complement CoQ10, the formula includes a massive 500 mg dose of reduced Glutathione, the body's master antioxidant. While CoQ10 works inside the mitochondrial membrane, glutathione operates throughout the cellular cytoplasm, aggressively scavenging free radicals and preventing lipid peroxidation. Together, they form an impenetrable antioxidant shield, protecting the delicate neural tissues from the oxidative damage that drives cognitive decline in complex chronic illnesses.

Because SynaQuell+ targets the root causes of neuroinflammation and cellular energy deficits, it may help manage a wide array of cognitive symptoms associated with Long COVID, ME/CFS, and dysautonomia:

The systemic metabolic support provided by this comprehensive formulation also extends to physical and energetic symptoms:

One of the primary challenges in nutritional supplementation for neurological health is ensuring that the active compounds actually absorb into the bloodstream and successfully cross the blood-brain barrier. Many standard supplements fail because they are destroyed in the gut or possess poor lipid solubility. SynaQuell+ overcomes this hurdle by utilizing advanced Phytosome technology for its most critical, hard-to-absorb ingredients: Coenzyme Q10 and Curcumin.

Phytosome technology (commercially known as Ubiqsome® for CoQ10 and Meriva® for Curcumin) involves binding the active botanical extract to a phospholipid matrix, typically derived from sunflower lecithin. Because human cellular membranes are also made of phospholipids, this biomimetic delivery system allows the nutrients to easily pass through the intestinal wall and cellular barriers. Clinical pharmacokinetic testing has demonstrated that CoQ10 Phytosome offers up to 9 times higher absorption than standard CoQ10, while Curcumin Phytosome vastly outperforms standard turmeric extracts, ensuring that these vital neuroprotective agents reach the brain tissues where they are needed most.

Similarly, the inclusion of DHA derived from vegan algal oil ensures a highly pure, triglyceride-form of this essential fatty acid, which is readily incorporated into neuronal membranes. By prioritizing these highly bioavailable forms, Thorne ensures that the clinical dosages provided in the formula translate directly into measurable physiological support, rather than simply passing through the digestive tract unabsorbed.

Because SynaQuell+ is formulated with therapeutic, clinical doses of its active ingredients—including 2.5 grams of BCAAs and 750 mg of BHB ketones—it cannot physically fit into standard capsules. Therefore, it is delivered as a powdered drink mix. The suggested use is to mix one scoop (approximately 12 grams) with at least 12 ounces of water, taken two times daily, or as recommended by your healthcare practitioner.

For individuals with complex chronic illnesses like ME/CFS or Long COVID, who often have highly sensitive nervous and digestive systems, practitioners frequently recommend a "low and slow" approach. Starting with a quarter or half scoop once daily allows the body to acclimate to the influx of amino acids and ketones. Because the formula contains active B-vitamins (like Riboflavin 5'-Phosphate) and energy-promoting compounds, it is generally best taken earlier in the day to prevent any potential interference with sleep architecture.

When mixing the powder, using a shaker bottle or a small frother can help ensure the lipid-bound phytosomes and amino acids dissolve smoothly. Taking the supplement alongside a small meal that contains some healthy fats can further enhance the absorption of the fat-soluble components like CoQ10, Resveratrol, and DHA.

While SynaQuell+ is generally well-tolerated, the comprehensive nature of the formula means there are several practical considerations and potential interactions to be aware of. The formula contains 220 mg of magnesium (sourced from bisglycinate chelate and magnesium BHB). In some sensitive individuals, magnesium supplements can cause gastrointestinal distress, including gas, bloating, or diarrhea. If these symptoms occur, reducing the dosage usually resolves the issue.

Crucially, the potent botanical extracts in the formula can interact with certain medications. Curcumin has been shown in animal and in vitro studies to reduce the therapeutic efficacy of specific chemotherapy drugs, including cyclophosphamide (Cytoxan) and irinotecan. Individuals undergoing active cancer treatments should strictly avoid concurrent use of curcumin-containing supplements. Additionally, due to the anti-platelet activity of resveratrol and DHA, individuals on high-dose blood thinners should consult their physician before starting this supplement.

As with all advanced nutritional interventions, this product is contraindicated in individuals with a history of hypersensitivity to any of its ingredients. Furthermore, Thorne explicitly warns that if you are pregnant or nursing, you should not use this product. Always consult with a qualified healthcare provider before introducing a multi-ingredient formula into your management protocol, especially when navigating the complexities of post-viral syndromes.

It is important to manage expectations regarding the timeline for cognitive improvement. While exogenous ketones (BHB) can provide a relatively rapid, short-term boost in mental clarity by supplying immediate alternative fuel to the brain, the deeper structural repairs take time. Rebuilding mitochondrial density, replenishing the cellular NAD+ pool, and downregulating chronic microglial activation are complex biological processes.

Clinical trials investigating NAD+ precursors and mitochondrial antioxidants typically run for 8 to 12 weeks before measuring significant changes in cognitive fatigue and executive function. Patients should view SynaQuell+ as a foundational tool for long-term neurological rehabilitation rather than a quick fix. Consistent, daily use over a period of several months, combined with aggressive pacing and symptom tracking, is usually required to experience the full neuroprotective and energy-restoring benefits of the formulation.

The scientific rationale for using the ingredients in SynaQuell+ to treat post-viral cognitive dysfunction is rapidly expanding. A landmark 2025 randomized, double-blind, placebo-controlled clinical trial published in eClinicalMedicine investigated the use of high-dose Nicotinamide Riboside (NR) in 58 patients with Long COVID. The study confirmed that NR supplementation successfully and safely resolved the cellular NAD+ deficit, increasing whole-blood NAD+ levels by 2.6- to 3.1-fold. Crucially, participants who took NR for at least 10 weeks reported significant self-assessed improvements from their own baselines in fatigue, sleep quality, and executive function.

Similarly, the use of exogenous ketones and ketogenic metabolic therapy is gaining significant traction. Researchers at the University of Southern California (USC) are currently conducting specialized clinical trials investigating low-carbohydrate interventions paired with BHB supplementation for Long COVID. Preclinical data strongly suggests that shifting the body into a state of ketosis can bypass the glucose hypometabolism seen in post-viral brains, lower systemic inflammation by inhibiting the NLRP3 inflammasome, and radically improve cellular energy levels, providing a direct mechanism for clearing brain fog.

The synergistic use of mitochondrial antioxidants and anti-inflammatory polyphenols is heavily supported by clinical data in the ME/CFS population. A highly cited study by Castro-Marrero et al. involving 207 ME/CFS patients demonstrated that daily administration of CoQ10 (alongside NADH) over 12 weeks resulted in a significant reduction in cognitive fatigue and general fatigue, alongside improved sleep and quality of life. The use of Phytosome technology (Ubiqsome®) further amplifies these results by ensuring the CoQ10 actually reaches the mitochondrial membranes.

Regarding neuroinflammation, an open-label study by van Campen et al. evaluated 52 patients with ME/CFS who were given 500 mg of curcumin complexed with phosphatidylcholine (the exact technology used in SynaQuell+) twice daily for 8 weeks. The results were striking: patients experienced a statistically significant reduction in CDC and CFS symptom scores, specifically reporting massive reductions in fatigue, sleep disturbances, and pain. This directly validates the use of highly bioavailable curcumin to calm the microglial activation driving post-viral symptoms.

The inclusion of BCAAs to combat cognitive fatigue is rooted in decades of neurological research, specifically the Central Fatigue Hypothesis pioneered by Newsholme and Blomstrand. Their research demonstrated that during periods of extreme physical or metabolic stress, depleted BCAA levels allow free tryptophan to flood the brain, causing massive spikes in serotonin that result in profound central nervous system exhaustion.

Modern metabolomic profiling has confirmed that this exact mechanism is at play in chronic illness. A landmark study on ME/CFS metabolic phenotypes published by Fluge et al. in the Journal of Clinical Investigation identified that impaired energy metabolism in chronic fatigue patients involves abnormal amino acid metabolism, specifically noting statistically significant reductions in BCAA levels. By supplementing with BCAAs, SynaQuell+ directly addresses this metabolic phenotype, helping to restore the delicate neurotransmitter balance required for motivation, focus, and cognitive clarity.

Living with the cognitive dysfunction of Long COVID, ME/CFS, or dysautonomia is an incredibly isolating experience. Because brain fog is invisible, it is frequently misunderstood or minimized by those who have never experienced the profound terror of losing a thought mid-sentence or the exhaustion of trying to process a simple email. Your cognitive symptoms are not a sign of weakness, anxiety, or a lack of effort. They are the direct result of a physiological energy crisis and measurable neuroinflammation within your central nervous system. Validating this biological reality is the first and most crucial step toward reclaiming your cognitive health.

While the science behind SynaQuell+™ is highly promising, it is important to remember that no single supplement is a cure for complex chronic conditions. Rebuilding mitochondrial health and calming a hyperactive immune system requires a comprehensive, multi-disciplinary approach. Supplements must be paired with aggressive pacing strategies to prevent post-exertional malaise, meticulous symptom tracking to identify specific triggers, and ongoing guidance from a medical team that understands the nuances of post-viral illness.

By addressing the brain's energy deficits with alternative fuels like BHB, replenishing NAD+ pools, and utilizing advanced phytosome technology to deliver potent anti-inflammatory polyphenols directly to the brain, SynaQuell+ offers a powerful tool to support your recovery. It provides the essential raw materials your neural networks need to repair, rebuild, and slowly lift the fog.

If you are struggling with debilitating brain fog, cognitive fatigue, or memory issues related to Long COVID or ME/CFS, discuss SynaQuell+ with your healthcare provider to see if this comprehensive neurological support formula is appropriate for your specific metabolic needs.